The global market for cosmetic surgery, facial aesthetics, and medical laser devices is expected to almost double in size, exceeding $3 billion by 2017, according to a new report published by iData Research.

The market for aesthetic botulinum toxin-A drugs, such as Botox Cosmetic, will grow to an estimated $543 million by 2017, while the aesthetic laser and light therapy markets for skin resurfacing, hair removal, and laser lipolysis are the fastest growing segments.

Last year, the overall Asia-Pacific (South Korean, Japanese and Australian) cosmetic surgery, facial aesthetics, and medical laser devices market amounted to over $715 million and is likely to show positive growth in future, where companies such as Allergan, Mentor, Q-Med, and Cutera are leaders in this marketspace, among many others.

The new report "Asia Pacific Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 (Japan, South Korea, Australia)" features detailed analysis of market revenues by device type, unit sales, average selling prices, market driving and limiting forces. In addition, the review incorporates comprehensive competitive landscape including manufacturer market shares and product portfolios as well as presents market outlook and forecasts up to 2017.


[Source: Business Wire/MarketWatch]